MARKETAXESS EXPANDS GLOBAL ACCESS FOR US TAXABLE MUNICIPAL BONDS TO THE UK, EUROPE AND SINGAPORE
NEW YORK and LONDON, April 01, 2020 (GLOBE NEWSWIRE) — MarketAxess Holdings Inc. (Nasdaq: MKTX), the operator of a leading […]
Infinera Unveils the Next Phase in the Evolution of Compact Modular Optical Transport Solutions
SUNNYVALE, Calif., April 01, 2020 (GLOBE NEWSWIRE) — Infinera (NASDAQ: INFN) unveiled today the expansion of the industry-leading Groove (GX) […]
Harpoon Therapeutics Appoints Two New Members to Its Board of Directors
Andrew R. Robbins, former Chief Operating Officer, Array BiopharmaDr. Joseph S. Bailes, former President of American Society of Clinical Oncology […]
Guardion Health Sciences Receives Initial Order from Malaysian Company for Exclusive Immuno-Supportive Formula
–Initial order for $875,000 from Astramune Sdn Bhd, a subsidiary of Ho Wah Genting Berhad–Formula designed to provide immune-supportive benefits–Formula […]
COLUMBIA FINANCIAL, INC. ANNOUNCES COMPLETION OF ROSELLE BANK ACQUISITION
FAIR LAWN, N.J., April 01, 2020 (GLOBE NEWSWIRE) — Columbia Bank MHC, Columbia Financial, Inc. (NASDAQ: CLBK) and Columbia Bank […]
Sandy Spring Bancorp Completes Acquisition of Revere Bank
OLNEY, Md., April 01, 2020 (GLOBE NEWSWIRE) — Sandy Spring Bancorp, Inc. (NASDAQ: SASR, “Sandy Spring”), the parent company of […]
Flexion Therapeutics Announces ZILRETTA® License Agreement and Provides Business Update Amid Coronavirus Pandemic
Company signs exclusive license agreement with Hong KongTainuo Pharma Ltd. (HK Tainuo) and Jiangsu Tainuo Pharmaceutical Co. Ltd. (Jiangsu Tainuo) […]
Microbot Medical Appoints Aileen Stockburger to the Board of Directors
HINGHAM, Mass., April 01, 2020 (GLOBE NEWSWIRE) — Microbot Medical Inc. (Nasdaq: MBOT) announced the appointment of Aileen Stockburger to […]
Plus Therapeutics Announces Dr. Gregory Stein as Head of Clinical Development
AUSTIN, Texas, April 01, 2020 (GLOBE NEWSWIRE) — Plus Therapeutics, Inc. (Nasdaq: PSTV) (the “Company”), today announced that Dr. Gregory Stein […]
FDA ACCEPTS MESOBLAST’S BIOLOGICS LICENCE APPLICATION FOR RYONCIL™ AND AGREES TO PRIORITY REVIEW
NEW YORK, April 01, 2020 (GLOBE NEWSWIRE) — Mesoblast Limited (Nasdaq: MESO; ASX:MSB), global leader in cellular medicines for inflammatory […]
